Genetic Technologies Ltd (NASDAQ:GENE)

1.22
Delayed Data
As of 3:36pm ET
 -0.03 / -2.40%
Today’s Change
0.70
Today|||52-Week Range
2.05
+5.17%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$19.8M

Company Description

Genetic Technologies Ltd. is a molecular diagnostics company that offers predictive testing and assessment tools to help physicians proactively manage women's health. Its product, BREVAGenplus, is a clinically validated risk assessment test for non-hereditary breast cancer. The company was founded on January 5, 1987 and is headquartered in Fitzroy, Australia.

Contact Information

Genetic Technologies Ltd.
60-66 Hanover Street
Fitzroy Victoria (vic) 3065
P:(138) 412-7000
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Paul Alexander KasianChairman & Chief Executive Officer
Kevin FischerChief Financial Officer & Secretary
Richard AllmanScientific Director
Diana NewportDirector-Quality & Business Operations